iSpecimen Inc. (ISPC)

NCM – Real Time Price. Currency in USD

4.54

-0.51 (-10.10%)

At close: May 12, 2026, 4:00 PM EDT

4.53

-0.01 (-0.14%)

Pre-market: May 13, 2026, 5:04 AM EDT

12.05.2026

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced that it acted as the exclusive placement agent in connection with a $2.5 million private placement for iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers.

09.05.2026

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

May 8, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it has priced a private placement with accredited investors for aggregate gross proceeds of approximately $2.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company.

24.04.2026

iSpecimen Announces 1-for-40 Reverse Stock Split

Woburn, Massachusetts--(Newsfile Corp. - April 24, 2026) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of 1-for-40. The reverse stock split will become effective at 4:30 p.m.

09.04.2026

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

Woburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ: ISPC), an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct shipment of biospecimens from supplier sites to customers, both domestically and internationally. By reducing reliance on centralized hub processing, the new model simplifies logistics and eliminates multi-step routing.

16.03.2026

iSpecimen Achieves Rapid Procurement Milestone for Influenza Research

Woburn, Massachusetts--(Newsfile Corp. - March 16, 2026) - iSpecimen Inc. (NASDAQ: ISPC) (the "Company"), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the responsiveness and capabilities of its site network. Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza.

12.03.2026

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

Strengthens iSpecimen's next-generation marketplace platform Woburn, MA, March 12, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (the “Company”) (NASDAQ: ISPC), a leading technology marketplace connecting researchers with biospecimen suppliers, today announced the launch of its new AI-powered Inventory Agent, a purpose-built tool designed to help accelerate the process of reviewing incoming biospecimen requests and matching them with available inventory across its global supplier network. The internally developed AI agent analyzes incoming request criteria and is designed to identify potential biospecimen matches, enabling the iSpecimen team to respond to research inquiries with greater speed and precision.

12.03.2026

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

Strengthens iSpecimen's next-generation marketplace platform Woburn, Massachusetts--(Newsfile Corp. - March 12, 2026) - iSpecimen Inc. (NASDAQ: ISPC) (the "Company"), a leading technology marketplace connecting researchers with biospecimen suppliers, today announced the launch of its new AI-powered Inventory Agent, a purpose-built tool designed to help accelerate the process of reviewing incoming biospecimen requests and matching them with available inventory across its global supplier network. The internally developed AI agent analyzes incoming request criteria and is designed to identify potential biospecimen matches, enabling the iSpecimen team to respond to research inquiries with greater speed and precision.

Videos

No Data

There is no data to display

Press releases

12.05.2026

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

09.05.2026

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

24.04.2026

iSpecimen Announces 1-for-40 Reverse Stock Split

09.04.2026

iSpecimen Inc. (ISPC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

iSpecimen Inc. (ISPC)

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Announces 1-for-40 Reverse Stock Split

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

iSpecimen Achieves Rapid Procurement Milestone for Influenza Research

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

Videos

No Data

Press releases

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Announces 1-for-40 Reverse Stock Split

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Announces 1-for-40 Reverse Stock Split

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

iSpecimen Achieves Rapid Procurement Milestone for Influenza Research

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

Videos

No Data

Press releases

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Announces 1-for-40 Reverse Stock Split

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

Search stocks

iSpecimen Inc. (ISPC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

iSpecimen Inc. (ISPC)

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Announces 1-for-40 Reverse Stock Split

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

iSpecimen Achieves Rapid Procurement Milestone for Influenza Research

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

Videos

No Data

Press releases

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Announces 1-for-40 Reverse Stock Split

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Announces 1-for-40 Reverse Stock Split

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

iSpecimen Achieves Rapid Procurement Milestone for Influenza Research

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

Videos

No Data

Press releases

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Announces 1-for-40 Reverse Stock Split

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time